Musk’s startup company Neuralink has tapped the University of Miami’s Miller School of Medicine to be the second site in the country to test whether its brain chip can give people who are paralyzed the ability to use mind to wirelessly control computers, smartphones and other electronic devices.

The University of Miami on Monday announced that it will be the second U.S.-based site for Elon Musk’s Neuralink’s PRIME Study.

Elon Musk’s Neuralink has selected Miami as a clinical trial site for its brain-computer interface. Musk’s Neuralink makes devices that link the human brain to computers, focusing on giving people with quadriplegia or paralysis the ability to control computers and devices with their thoughts.